Log In
Print
BCIQ
Print
Print this Print this
 

RSLV-132

  Manage Alerts
Collapse Summary General Information
Company Resolve Therapeutics LLC
DescriptionMono-specific nuclease Fc-fusion protein that targets and removes immune complexes which are activating the inflammatory cascade
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$255.0M

0

$247.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today